The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.

Say goodbye to the classic ClinicalTrials.gov!

The classic ClinicalTrials.gov website will be retired on June 25, 2024. Please use the modernized ClinicalTrials.gov. For more information, see ClinicalTrials.gov Modernization.

Key Record Dates

ClinicalTrials.gov Identifier:	NCT04475939
Brief Title:	Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-small Cell Lung Cancer (ZEAL-1L)

First Submitted :	July 14, 2020
First Submitted that Met QC Criteria :	July 14, 2020
First Posted :	July 17, 2020

Last Update Submitted that Met QC Criteria :	February 2, 2024
Last Update Posted :	February 5, 2024

To Top